Cipla Ltd

Cipla Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Cipla Ltd

₹ 1,466 -0.41%
21 Nov - close price
cipla.com BSE: 500087 NSE: CIPLA
About

Cipla is engaged in the Business of Pharmaceuticals.(Source : 202003 Annual Report Page No:157)

Key Points

Market Leadership[1]
# 3rd largest in the India domestic Rx market
# Leadership in Gx
# 1st rank in Respiratory
# Top 5 in Urology and Anti-infectives.
# Over 5 Lac+ no of downloads - Digital Breathe free
# 7,500+ field force detailing to HCPs across the country – 85% of physicians prescribe at least one Cipla product.
# 3rd largest player in private Rx market in SAGA
# Fastest growing generic player in North America.

Website BSE NSE
  • Market Cap ₹ 1,18,353 Cr.
  • Current Price ₹ 1,466
  • High / Low ₹ 1,702 / 1,178
  • Stock P/E 28.0
  • Book Value ₹ 361
  • Dividend Yield 0.89 %
  • ROCE 18.6 %
  • ROE 15.3 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 22.2%

Cons

  • The company has delivered a poor sales growth of 6.02% over past five years.
  • Company has a low return on equity of 13.4% over last 3 years.
  • Promoter holding has decreased over last 3 years: -5.20%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Part of Nifty 50 BSE 500 BSE Healthcare BSE 100 BSE 200

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
3,823 3,884 3,735 3,846 4,151 3,536 3,566 4,318 4,234 4,381 4,037 4,501 4,775
2,863 2,877 3,109 2,852 3,090 2,707 2,854 3,114 3,009 3,025 3,209 3,141 3,337
Operating Profit 961 1,007 625 994 1,061 829 711 1,205 1,225 1,356 828 1,360 1,438
OPM % 25% 26% 17% 26% 26% 23% 20% 28% 29% 31% 21% 30% 30%
214 98 330 147 107 208 -1 158 319 265 595 214 289
Interest 8 6 6 2 8 6 9 0 7 9 5 5 3
Depreciation 139 134 137 128 176 130 162 136 180 135 137 138 146
Profit before tax 1,028 965 813 1,010 985 901 540 1,226 1,358 1,477 1,281 1,430 1,578
Tax % 24% 24% 20% 25% 27% 25% 34% 27% 24% 25% 19% 26% 25%
782 731 653 759 720 679 355 895 1,030 1,114 1,038 1,056 1,178
EPS in Rs 9.70 9.06 8.09 9.41 8.93 8.41 4.40 11.09 12.75 13.80 12.86 13.08 14.59
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
8,202 9,457 10,132 12,118 10,768 11,390 12,374 12,659 11,303 15,381 14,345 16,574 17,694
6,067 7,460 8,162 10,064 9,155 9,194 9,869 9,952 8,235 11,670 10,992 12,090 12,712
Operating Profit 2,135 1,996 1,969 2,053 1,613 2,196 2,505 2,707 3,067 3,711 3,353 4,484 4,982
OPM % 26% 21% 19% 17% 15% 19% 20% 21% 27% 24% 23% 27% 28%
213 273 140 280 113 257 575 893 654 742 640 1,434 1,363
Interest 33 128 136 147 39 12 17 36 45 27 22 20 23
Depreciation 303 324 433 443 500 530 570 600 469 547 596 588 555
Profit before tax 2,012 1,818 1,540 1,744 1,187 1,911 2,493 2,964 3,208 3,880 3,375 5,310 5,767
Tax % 25% 24% 23% 16% 18% 23% 24% 22% 23% 24% 26% 23%
1,507 1,388 1,181 1,462 975 1,469 1,888 2,318 2,468 2,958 2,513 4,077 4,387
EPS in Rs 18.77 17.29 14.71 18.20 12.12 18.24 23.44 28.75 30.61 36.66 31.14 50.50 54.33
Dividend Payout % 11% 12% 14% 11% 16% 16% 13% 14% 16% 14% 27% 26%
Compounded Sales Growth
10 Years: 6%
5 Years: 6%
3 Years: 14%
TTM: 13%
Compounded Profit Growth
10 Years: 11%
5 Years: 17%
3 Years: 18%
TTM: 51%
Stock Price CAGR
10 Years: 9%
5 Years: 25%
3 Years: 17%
1 Year: 25%
Return on Equity
10 Years: 12%
5 Years: 13%
3 Years: 13%
Last Year: 15%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 161 161 161 161 161 161 161 161 161 161 161 161 162
Reserves 8,709 9,931 10,930 11,825 12,640 13,952 15,621 17,242 19,766 22,352 24,477 27,812 28,972
966 877 1,381 1,132 324 174 0 6 52 23 50 46 43
1,658 1,955 2,721 2,121 2,482 2,807 2,637 2,997 2,984 2,912 2,908 3,034 3,415
Total Liabilities 11,493 12,924 15,192 15,239 15,607 17,095 18,419 20,406 22,964 25,449 27,596 31,053 32,591
3,418 3,524 3,594 3,826 4,236 4,320 4,189 4,151 4,066 3,910 3,809 3,719 3,862
CWIP 350 377 361 551 556 463 297 320 355 268 504 670 579
Investments 2,602 3,587 4,421 4,256 4,286 4,637 5,815 7,190 9,726 10,974 11,909 13,794 13,733
5,123 5,436 6,816 6,606 6,530 7,675 8,117 8,745 8,816 10,298 11,374 12,871 14,417
Total Assets 11,493 12,924 15,192 15,239 15,607 17,095 18,419 20,406 22,964 25,449 27,596 31,053 32,591

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
1,381 1,812 1,051 1,728 2,207 1,117 1,468 2,018 3,460 2,773 3,035 3,727
-2,064 -1,467 -1,194 -1,206 -1,192 -593 -1,148 -1,127 -3,361 -2,464 -2,758 -2,883
733 -404 180 -547 -1,011 -351 -473 -694 -66 -427 -425 -709
Net Cash Flow 50 -59 37 -25 5 173 -153 197 33 -117 -148 135

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 73 67 74 57 66 75 93 103 98 66 73 59
Inventory Days 279 244 302 217 234 267 232 255 274 215 242 234
Days Payable 99 93 126 74 114 139 120 136 133 97 121 121
Cash Conversion Cycle 254 217 250 201 185 203 206 222 239 184 195 172
Working Capital Days 146 126 141 122 116 132 145 146 150 124 177 161
ROCE % 24% 19% 14% 14% 9% 14% 16% 17% 17% 18% 13% 19%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
36.11% 33.63% 33.61% 33.61% 33.61% 33.55% 33.46% 33.46% 33.46% 33.46% 30.91% 30.93%
24.36% 26.65% 27.65% 27.69% 28.39% 27.42% 25.49% 25.74% 25.73% 25.82% 27.82% 28.80%
21.52% 21.99% 21.33% 21.47% 20.87% 21.83% 24.05% 23.90% 24.05% 24.15% 24.66% 23.95%
0.00% 0.00% 0.00% 0.21% 0.21% 0.21% 0.21% 0.21% 0.21% 0.21% 0.21% 0.21%
18.01% 17.73% 17.40% 17.00% 16.91% 16.99% 16.76% 16.68% 16.53% 16.36% 16.40% 16.11%
No. of Shareholders 4,51,3654,18,5844,18,9103,88,8644,04,1824,75,2934,66,5154,26,8634,25,7314,36,1544,63,5694,70,234

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls